The IARS 2017 Annual Meeting and International Science Symposium, held May 6-9, 2017 at the Grand Hyatt Washington in Washington, DC
Apply Now. Deadline April 30, 2017
The IARS 2017 Annual Meeting and International Science Symposium will occur May 6-9, 2017 at the Grand Hyatt Washington in Washington, DC
Program prices start at $225 for the year--as little as $15 per resident.
IARS Members get 10% off! email@example.com
The IARS is a nonpolitical, not-for-profit medical society founded in 1922 to advance and support scientific research and education related to anesthesia, and to improve patient care through basic research. The IARS contributes over $1 million annually to fund anesthesia research; provides a forum for anesthesiology leaders to share information and ideas; maintains a worldwide membership of more than 12,000 physicians, physician residents, and others with doctoral degrees, as well as health professionals in anesthesia-related practice; sponsors the SmartTots initiative in partnership with the FDA; and publishes the monthly Anesthesia & Analgesia journal in print and online as well as the clinical companion journal A&A Case Reports, published semi-monthly.
2/14/2017 12:00:00 PM
The IARS has joined the World Federation of Societies of Anesthesiologists (WFSA) SAFE-T Consortium. The SAFE-T Consortium (Safe Anaesthesia For Everybody – Today) is a global collaboration of industry and organizations committed to the advancement of patient safety and the International Standards for a Safe Practice of Anesthesia.
2/14/2017 6:00:00 AM
The IARS Board of Trustees has issued the following statement regarding the IARS 2017 Annual Meeting and International Symposium and the U.S. Executive Order on travel restrictions
The IARS is seeking candidates for the position of Program Officer for the IARS-FDA SmartTots Public-Private Partnership (PPP). The position is a new, part-time, academic contract role created to support the SmartTots research direction and the design of new research studies. SmartTots funds research to increase the safety of anesthetic and sedative drugs for the millions of children who undergo anesthesia and sedation each year. Learn more at SmartTots!
12/16/2016 1:11:00 PM
On Wednesday, December 14, the United States Food and Drug Administration (FDA) released a Drug Safety Communication warning that; "repeated or lengthy use of general anesthetic or sedation drugs during surgeries or procedures in children younger than three years of age or in pregnant women during the final trimester may affect development of children’s brains." The FDA defined lengthy as greater than three hours of exposure.
12/2/2016 10:34:00 AM
As the Zika epidemic spreads to the United States, the potential for contracting the disease via blood transfusion has emerged as a serious concern. The problem of transfusion-related Zika virus transmission—and recommended strategies to reduce that risk—are outlined in a special article in Anesthesia & Analgesia. Anesthesia & Analgesia is published by Wolters Kluwer.
© 2017 International Anesthesia Research Society
Established in 1922